Immune response scenario and vaccine development for SARS-CoV-2 infection
Review
[키워드] antiviral drug
approach
asymptomatic infection
build
caused
China
clinical presentation
Complete
Coronavirus infection
COVID-19
COVID-19 pandemic
Cytokine storm
death
disease
Disease progression
effective
Effectiveness
element
flu
Health
helping
immune response
immune system
in viral
in vitro
include
induce
management
MERS
multiple organ failure
natural immune response
Neutralizing
Novel coronavirus
patient’s death
Pneumonia
Prevent
promoter
Prophylaxis
Protein
protein S
Randomized
responsible
SARS CoV-2
SARS-CoV-2
SARS-COV-2 infection
spike glycoprotein
supportive care
Symptom
the vaccine
therapy
treat
Trial
Vaccine
Vaccine development
Vaccines
while
[DOI] 10.1016/j.intimp.2021.107439 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2021.107439 PMC 바로가기 [Article Type] Review